Immunotherapy as a treatment strategy in advanced stage and recurrent endometrial cancer: Review of current phase III immunotherapy clinical trials

Authors

Ramez N Eskander, University of California San Diego
Matthew A Powell, Washington University School of Medicine in St. Louis

Journal

Therapeutic Advances in Medical Oncology

Publication Date

1-1-2021

Volume

13

First Page

17588359211001199

Document Type

Open Access Publication

DOI

10.1177/17588359211001199

Rights and Permissions

Eskander RN, Powell MA. Immunotherapy as a treatment strategy in advanced stage and recurrent endometrial cancer: review of current phase III immunotherapy clinical trials. Ther Adv Med Oncol. 2021 Mar 16;13:17588359211001199. doi: 10.1177/17588359211001199. © The Author(s), 2021. Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).

Recommended Citation

Eskander, Ramez N and Powell, Matthew A, "Immunotherapy as a treatment strategy in advanced stage and recurrent endometrial cancer: Review of current phase III immunotherapy clinical trials." Therapeutic Advances in Medical Oncology. 13, 17588359211001199 (2021).
https://digitalcommons.wustl.edu/oa_4/188